Home ProductsVeterinary Injectable Drugs

Treating Mycoplasma Veterinary Injectable Drugs Tilmicosin 30% Injection

Certification
China Zhengzhou MCT International Co.,Ltd certifications
China Zhengzhou MCT International Co.,Ltd certifications
I'm Online Chat Now

Treating Mycoplasma Veterinary Injectable Drugs Tilmicosin 30% Injection

Treating Mycoplasma Veterinary Injectable Drugs Tilmicosin 30% Injection
Treating Mycoplasma Veterinary Injectable Drugs Tilmicosin 30% Injection Treating Mycoplasma Veterinary Injectable Drugs Tilmicosin 30% Injection

Large Image :  Treating Mycoplasma Veterinary Injectable Drugs Tilmicosin 30% Injection

Product Details:
Place of Origin: CHINA
Brand Name: CHOOSING
Certification: GMP COA
Model Number: 50ml 100ml
Payment & Shipping Terms:
Minimum Order Quantity: 20000bottles
Price: Negotiable
Packaging Details: 50ml/bottle, 100ml/bottle
Delivery Time: 15-20days
Payment Terms: L/C, D/A, D/P, Western Union, T/T
Supply Ability: 3000liters per day

Treating Mycoplasma Veterinary Injectable Drugs Tilmicosin 30% Injection

Description
Apply To:: Cattle Sheep Horse Pig Pets Breeding Animals Origin:: Henan
Appearance:: Liquid Composition:: Tilmicosin 30%
Shelf Life:: 24 Months Name: Tilmicosin 30% Injection
High Light:

veterinary antibiotic injection

,

oxytetracycline injection veterinary

Treating Mycoplasma Drugs Tilmicosin 30% Injection For Cattle Camel

 

Composition

 

Contains per ml. :
Tilmicosin base 300 mg.
Solvents ad. 1 ml.

 

Indications

This product is indicated for the treatment of respiratory infections in cattle and sheep associated with Mannheimia haemolytica, Pasteurella spp. and other tilmicosin-susceptible micro-organisms, and for the treatment of ovine mastitis associated with Staphylococcus aureus and Mycoplasma spp. Additional indications include the treatment of interdigital necrobacillosis in cattle (bovine pododermatitis, foul in the foot) and ovine footrot.

 

Contra indications

Hypersensitivity or resistance to tilmicosin.
Concurrent administration of other macrolides, lincosamides or ionophores.
Administration to equine, porcine or caprine species.
Administration to cattle producing milk for human consumption or to lambs weighing 15 kg or less.


Intravenous administration
Do not use in lactating animals. During pregnancy, use only after a risk/benefit assessment by a veterinarian. Do not use in heifers within 60 days of calving.
Do not use together with adrenalin or β-adrenergic antagonists such as propranolol.

 

Side effects

Occasionally, a soft diffuse swelling may occur at the injection site which subsides without further treatment. The acute manifestations of multiple injections of large subcutaneous doses (150 mg/kg) in cattle included moderate electrocardiographic changes accompanied by mild focal myocardial necrosis, marked injection site oedema, and death. Single subcutaneous injections of 30 mg/kg in sheep produced increased respiration rate, and at higher levels (150 mg/kg) ataxia, lethargy and drooping of the head.

 

Dosage

For subcutaneous injection:
Cattle :pneumonia 1 ml per 30 kg body weight (10 mg/kg).
Cattle: interdigital necrobacillosis : 0.5 ml per 30 kg body weight (5 mg/kg).
Sheep pneumonia and mastitis 1 ml per 30 kg body weight (10 mg/kg).
Sheep footrot 0.5 ml per 30 kg body weight (5 mg/kg).

 

Withdrawal times

 

For meat :
Cattle 60 days.
Sheep 42 days.
For milk :
Sheep 15 days.

 

WARNING:

KEEP OUT OF CHILDREN

 

Treating Mycoplasma Veterinary Injectable Drugs Tilmicosin 30% Injection 0

Contact Details
Zhengzhou MCT International Co.,Ltd

Contact Person: Coco Zhao

Tel: +8619937029725

Send your inquiry directly to us (0 / 3000)